DD258234A1 - PROCESS FOR THE PREPARATION OF PYRIDO / 3 ', 2': 4,5 / THIENO / 2,3-E / IMIDAZO- / 1,2-C / PYRIMIDINES AND STRUCTURE ANALOGER -PYRIMIDO / 1,2-C / PYRIMIDINE BZW. -1,3-diazepino / 1.2-C / PYRIMIDINES - Google Patents
PROCESS FOR THE PREPARATION OF PYRIDO / 3 ', 2': 4,5 / THIENO / 2,3-E / IMIDAZO- / 1,2-C / PYRIMIDINES AND STRUCTURE ANALOGER -PYRIMIDO / 1,2-C / PYRIMIDINE BZW. -1,3-diazepino / 1.2-C / PYRIMIDINES Download PDFInfo
- Publication number
- DD258234A1 DD258234A1 DD30047687A DD30047687A DD258234A1 DD 258234 A1 DD258234 A1 DD 258234A1 DD 30047687 A DD30047687 A DD 30047687A DD 30047687 A DD30047687 A DD 30047687A DD 258234 A1 DD258234 A1 DD 258234A1
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- thieno
- pyrimidines
- pyrido
- pyrimidine
- imidazo
- Prior art date
Links
Abstract
Die Erfindung betrifft ein Verfahren zur Herstellung von Pyrido/3,2:4,5/thieno/2,3-e/imidazo/1,2-c/pyrimidinen sowie strukturanaloger -pyrimido/1,2-c/pyrimidine bzw. -1,3-diazepino/1,2-c/pyrimidinen der allgemeinen Formel I. Es ist das Ziel der Erfindung, diese Verbindungen aus leicht zugaenglichen Reaktanden auf einfache Weise mit hohen Ausbeuten darzustellen. Die Aufgabe besteht darin, einen technisch gangbaren Syntheseweg aufzufinden. Die Aufgabe wird geloest durch Umsetzung von 3-(2-Chlor-ethyl)pyrido/3,2:4,5/thieno/3,2-d/pyrimidin-4(3H)-onen mit 1,v-Diaminoalkanen unter rueckfliessenden Reaktionsbedingungen, ggfs. unter Zusatz weiterer organischer Loesungsmittel, vorzugsweise DMF. Die erhaltenen Verbindungen sind biologisch aktiv und koennen z. B. auf Grund ihrer antianaphylaktischen Wirkung Bedeutung fuer die pharmazeutische Industrie erlangen. Formel IThe invention relates to a process for the preparation of pyrido / 3,2: 4,5 / thieno / 2,3-e / imidazo / 1,2-c / pyrimidines and structurally analogous pyrimido / 1,2-c / pyrimidines or 1,3-diazepino / 1,2-c / pyrimidines of general formula I. It is the object of the invention to easily prepare these compounds from readily available reactants in high yields. The task is to find a technically feasible synthetic route. The object is achieved by reacting 3- (2-chloroethyl) pyrido / 3,2: 4,5 / thieno / 3,2-d / pyrimidin-4 (3H) -ones with 1, v-diaminoalkanes with refluxing Reaction conditions, if necessary with the addition of further organic solvents, preferably DMF. The compounds obtained are biologically active and can, for. B. gain importance for the pharmaceutical industry due to their antianaphylactic effect. Formula I
Description
bzw. deren Säureadditionssalze, vorzugsweise deren Hydrochloride, umgesetzt werden, wobeior their acid addition salts, preferably their hydrochlorides, are reacted, wherein
R1 = niedrig Alkyl (C1-C3), (un)substituiert Aryl;R 1 = lower alkyl (C 1 -C 3 ), (un) substituted aryl;
R2 = H, CH3, (un)substituiert Aryl;R 2 = H, CH 3 , (un) substituted aryl;
R3 = H, CH3, Benzyl;R 3 = H, CH 3, benzyl;
R4 = CH3, (un)substituiert Afyl;R 4 = CH 3 , (un) substituted Afyl;
bzw. R2R3 gemeinsam das-(CH2)4-Strukturelement;or R 2 R 3 together den- (CH 2 ) 4 -Strukturelement;
bzw. R3R4 gemeinsam das -(CH2)4-Strukturelement undor R 3 R 4 together the - (CH 2 ) 4 structural element and
η = 2,3 oder 4 bedeuten.η = 2,3 or 4 mean.
2. Verfahren nach Punkt 1, dadurch gekennzeichnet, daß den Diaminoalkanen der allgemeinen Formel III organische Lösungsmittel, vorzugsweise DMF, zugemischt werden können.2. The method according to item 1, characterized in that the diaminoalkanes of the general formula III organic solvents, preferably DMF, can be added.
3. Verfahren nach Punkt 1 und 2, dadurch gekennzeichnet, daß die Reaktionszeit in homogener Lösung 15-30 min beträgt.3. The method according to item 1 and 2, characterized in that the reaction time in homogeneous solution is 15-30 min.
Die Erfindung betrifft ein Verfahren zur Herstellung tetra- und pentacyclischer Pyrimidine der allgemeinen Formel I. Derartige Verbindungen können als biologisch aktive Substanzen z. B. auf Grund ihrer antianaphylaktischen Wirkung Bedeutung als Pharmaka erlangen oder zu deren Herstellung Verwendung finden. Die Erfindung ist weiterhin auch für die chemische Industrie von Interesse.The invention relates to a process for the preparation of tetracyclic and pentacyclic pyrimidines of the general formula I. Such compounds can be used as biologically active substances z. B. due to their antianaphylactic effect gain importance as pharmaceuticals or to find their use. The invention is also of interest to the chemical industry.
Pyrido[3', 2':4,5]thieno[2,3-e]imidazo[1,2-c]pyrimidine, Pyrido[3', 2':4,5]thieno[2,3-e]pyrimido[1,2-c]pyrimidine, Pyrido[3', 2':4,5]thieno[2,3-e]1,3-diazepino[1,2-c]pyrimidine, Imidazo (bzw. Pyrimido)[1", 2": 3', 4']pyrimido[5', 6': 5,4]thieno[2,3-b]chinoline sind in der Fach- und Patentliteratur noch nicht beschrieben.Pyrido [3 ', 2': 4,5] thieno [2,3-e] imidazo [1,2-c] pyrimidines, pyrido [3 ', 2': 4,5] thieno [2,3-e] pyrimido [1,2-c] pyrimidines, pyrido [3 ', 2': 4,5] thieno [2,3-e] 1,3-diazepino [1,2-c] pyrimidines, imidazo (or pyrimido) [1 ", 2": 3 ', 4'] pyrimido [5 ', 6': 5,4] thieno [2,3-b] quinolines are not yet described in the technical and patent literature.
Ziel der Erfindung ist es, derartige Verbindungen aus leicht zugänglichen Reaktanden in einfacher Weise mit hohen Ausbeuten herzustellen.The aim of the invention is to produce such compounds from readily available reactants in a simple manner with high yields.
-2- ZÖ8Z34 Darlegung des Wesens der Erfindung-2- ZÖ8Z34 Presentation of the essence of the invention
Aufgabe der Erfindung ist es, einen technisch anwendbaren Syntheseweg zur Herstellung von substituierten tetra- und pentacyclischen Pyrimidinen der allgemeinen Formel I aufzufinden. Erfindungsgemäß wird die Aufgabe dadurch gelöst, daß 3-(2-Chlor-ethyl)pyrido[3', 2':4,5]thieno[3,2-d]pyrimidin-4(3H)-one der allgemeinen Formel II,The object of the invention is to find a technically applicable synthesis route for the preparation of substituted tetra- and pentacyclic pyrimidines of the general formula I. According to the invention the object is achieved in that 3- (2-chloro-ethyl) pyrido [3 ', 2': 4,5] thieno [3,2-d] pyrimidin-4 (3H) -ones of the general formula II,
: O : O
wobei R1, R2, R3 und R4 die nachfolgend genannten Bedeutungen aufweisen:where R 1 , R 2 , R 3 and R 4 have the meanings given below:
R1 = niedrig Alkyl (Ci-C3), (un)substituiert Aryl;R 1 = lower alkyl (C 1 -C 3 ), (un) substituted aryl;
R2 = H, CH3, (u η (substituiert Aryl;R 2 = H, CH 3 , (u η (substituted aryl;
R3 = H, CH3, Benzyl;R 3 = H, CH 3, benzyl;
R4 = CH3, (un)substituiert Aryl;R 4 = CH 3 , (un) substituted aryl;
bzw. R2R3 gemeinsam das-(CH2)4-Strukturelement;or R 2 R 3 together den- (CH 2 ) 4 -Strukturelement;
bzw. R3R4gemeinsam das-(CH2)4-Strukturelement bedeuten, durch rückfließendes Erhitzen mit Ι,ω-Diaminoalkanen der allgemeinen Formel III,or R 3 R 4 together den- (CH 2 ) 4 structural element, by refluxing with Ι, ω-diaminoalkanes of the general formula III,
H2N(CH2)nNH2 IIIH 2 N (CH 2 ) n NH 2 III
wobei η = 2,3 oder 4 bedeutet,where η = 2,3 or 4,
ggfs. auch in Anwesenheit üblicher organischer Lösungsmittel wie Dioxan, Dimethylsulfoxid, Alkanole (Ci-C4) oder vorzugsweise Dimethylformamid zu den tetra- bzw. pentacyclischen Pyrimidinen der allgemeinen Formel I,if necessary. Also in the presence of conventional organic solvents such as dioxane, dimethyl sulfoxide, alkanols (Ci-C 4 ) or preferably dimethylformamide to the tetra- or pentacyclic pyrimidines of general formula I,
wobei R1, R2, R3, R4 und η die oben genannten Bedeutungen aufweisen, bzw. deren Säureadditionssalzen, vorzugsweise deren Hydrochloriden, umgesetzt werden.where R 1 , R 2 , R 3 , R 4 and η have the abovementioned meanings, or their acid addition salts, preferably their hydrochlorides, are reacted.
Die Darstellung der literaturunbekannten Verbindungen der allgemeinen Formel Il erfolgt durch Einwirkung von vorzugsweise Phosphoroxidchlorid oder anderen anorganischen Säurechloriden wie Thionyl- oder Sulfurylchlorid auf 3-(2-Hydroxyethyl)pyrido[3', 2':4,5]thieno[3,2-d]pyrimidin-4(3H)-one der allgemeinen Formel IV,The preparation of the novel compounds of the formula II is carried out by the action of preferably phosphorus oxychloride or other inorganic acid chlorides such as thionyl or sulfuryl chloride on 3- (2-hydroxyethyl) pyrido [3 ', 2': 4,5] thieno [3,2- d] pyrimidin-4 (3H) -ones of general formula IV,
2CH2 OH O 2 CH 2 OH O
wobei R1, R2, R3 und R4 die oben genannten Bedeutungen aufweisen.wherein R 1 , R 2 , R 3 and R 4 have the meanings given above.
Ausführungsbeispieleembodiments
Die Erfindung soll nachstehend an 8 Ausführungsbeispielen näher erläutert werden.The invention will be explained in more detail below to 8 exemplary embodiments.
5,7-Dimethyl-9-phenyl-2,3-dihydro-pyrido[3', 2':4,5]thieno[2,3-e]imidazo[1,2-c]pyrimidin I; R1 = R2 = CH3, R3 = H, R4 = C6H5,5,7-dimethyl-9-phenyl-2,3-dihydro-pyrido [3 ', 2': 4,5] thieno [2,3-e] imidazo [1,2-c] pyrimidine I; R 1 = R 2 = CH 3 , R 3 = H, R 4 = C 6 H 5 ,
6,0g 3-(2-Chlor-ethyl)-2,9-dimethyl-7-phenyl-pyrido[3', 2':4,5]thieno[3,2-d]pyrimidin-4(3H)-on (II; R1 = R2 = CH3i R3 = H, R4 = C6H5; Schmp.:254-256°C[Toluen]; Ausbeute: 75%) werden in einer Mischung aus je 75 ml 1,2-Diamino-ethanmonohydrat6.0 g of 3- (2-chloroethyl) -2,9-dimethyl-7-phenylpyrido [3 ', 2': 4,5] thieno [3,2-d] pyrimidin-4 (3H) - on (II; R 1 = R 2 = CH 3i R 3 = H, R 4 = C 6 H 5 ; mp: 254-256 ° C [toluene]; yield: 75%) are dissolved in a 75 ml 1,2-diamino-ethanmonohydrat
und DMF 30min rückfließend erhitzt. Nach dem Erkaltenwird der gebildete Niederschlag abgesaugt, mit Methanol und anschließend mit Wasser gewaschen und getrocknetand DMF refluxed for 30 minutes. After cooling, the precipitate formed is filtered off with suction, washed with methanol and then with water and dried
Schmp.: 323-325°C(Dioxan/DMF9:1 v/v); Ausbeute: 78%. Mp: 323-325 ° C (dioxane / DMF9: 1 v / v); Yield: 78%.
6,8-Dimethyl-10-phenyl-3,4-dihydro-2H-pyrido[3', 2':4,5]thieno[2,3-e]pyrimido[1,2-c]pyrimidin I; R1 = R2 = CH3, R3 = H, R4 = C6H6, η = 36,8-dimethyl-10-phenyl-3,4-dihydro-2H-pyrido [3 ', 2': 4,5] thieno [2,3-e] pyrimido [1,2-c] pyrimidine I; R 1 = R 2 = CH 3 , R 3 = H, R 4 = C 6 H 6 , η = 3
6,0g der im Beispiel 1 genannten Chlor-ethylverbindung der allgemeinen Formel Il werden mit 60 ml 1,3-Diaminopropan, jedoch ohne DMF, analog Beispiel 1 umgesetzt und aufgearbeitet.6.0 g of the chloro-ethyl compound of the general formula II mentioned in Example 1 are reacted with 60 ml of 1,3-diaminopropane, but without DMF, analogously to Example 1 and worked up.
Schmp.: 295-299°C(Dioxan); Ausbeute: 70%.Mp: 295-299 ° C (dioxane); Yield: 70%.
7,9-Dimethyl-11-phenyl-1,3,4,5-tetrahydro-pyrido[3', 2':4,5]thieno[2,3-e]1,3-diazepino[1,2-c]pyrimidin I; R1 = R2 = CH3, R3 = H, R4 = C6H6, η = 47,9-dimethyl-11-phenyl-1,3,4,5-tetrahydropyrido [3 ', 2': 4,5] thieno [2,3-e] 1,3-diazepino [1,2- c] pyrimidine I; R 1 = R 2 = CH 3 , R 3 = H, R 4 = C 6 H 6 , η = 4
0,5g der im Beispiel 1 genannten Chlor-ethylverbindung der allgemeinen Formel Il werden mit 3,0ml 1,4-Diaminobutan 60min rückfließend erhitzt. Nach dem Erkalten wird dem Reaktionsansatz bis zur Trübung Wasser hinzugefügt. Nach Aufbewahrung des Reaktionsansatzes bei 40C wird der Niederschlag abgesaugt, mit Wasser gewaschen und getrocknet.0.5 g of the chloro-ethyl compound of the general formula II mentioned in Example 1 are refluxed with 3.0 ml of 1,4-diaminobutane for 60 min. After cooling, water is added to the reaction mixture until cloudy. After storage of the reaction mixture at 4 0 C, the precipitate is filtered off with suction, washed with water and dried.
Schmp.: 232-238°C (DMF/Wasser); Ausbeute: 25%.Mp: 232-238 ° C (DMF / water); Yield: 25%.
7-Methyl-5,9-diphenyl-2,3-dihydro-pyrido/3', 2':4,5]thieno[2,3-e]imidazo[1,2-c]pyrimidin I; R1 = R4 = C6H5, R3 = H, R2 = CH3,7-methyl-5,9-diphenyl-2,3-dihydro-pyrido / 3 ', 2': 4,5] thieno [2,3-e] imidazo [1,2-c] pyrimidine I; R 1 = R 4 = C 6 H 5 , R 3 = H, R 2 = CH 3 ,
6,0g 3-(2-Chlor-ethyl)-9-methyl-2,7-diphenyl-pyrido[3', 2':4,5]thieno[3,2-d]pyrimidin-4(3H)-on (II; R1 = R4 = C6H5, R3 = H, R2 = CH3; Schmp.: 252-254°C [Chloroform/Methanol]; Ausbeute: 92%) und 1,2-Diamino-ethanmonohydrat werden analog Beispiel 1 umgesetzt und aufgearbeitet.6.0 g of 3- (2-chloro-ethyl) -9-methyl-2,7-diphenyl-pyrido [3 ', 2': 4,5] thieno [3,2-d] pyrimidine-4 (3H) - on (II; R 1 = R 4 = C 6 H 5 , R 3 = H, R 2 = CH 3 , mp: 252-254 ° C [chloroform / methanol]; yield: 92%) and 1,2- Diamino-ethane monohydrate are reacted and worked up analogously to Example 1.
Schmp.: 273-278°C (Dioxan); Ausbeute: 74%.M.p .: 273-278 ° C (dioxane); Yield: 74%.
8-Methyl-6,10-diphenyl-3,4-dihydro-2H-pyrido[3', 2':4,5]thieno[2,3-e]pyrimido[1,2-c]pyrimidin I; R1 = R4 = C6H5, R3 = H, R2 = CH3, η = 38-methyl-6,10-diphenyl-3,4-dihydro-2H-pyrido [3 ', 2': 4,5] thieno [2,3-e] pyrimido [1,2-c] pyrimidine I; R 1 = R 4 = C 6 H 5 , R 3 = H, R 2 = CH 3 , η = 3
6,0g der im Beispiel 4 genannten Chlor-ethylverbindung der allgemeinen Formel Il werden in einer Mischung aus je 60ml 1,3-Diamino-propan und DMF analog Beispiel 1 umgesetzt und aufgearbeitet.6.0 g of the chloroethyl compound of the general formula II mentioned in Example 4 are reacted and worked up analogously to Example 1 in a mixture of 60 ml each of 1,3-diamino-propane and DMF.
Schmp.: 278-2810C (Dioxan/Wasser); Ausbeute: 54%.M.p .: 278-281 0 C (dioxane / water); Yield: 54%.
5,7,8,9-Tetramethyl-2,3-dihydro-pyrido[3', 2':4,5]thieno[2,3-e]imidazol[1,2-c]pyrimidin I; R1 = R2 = R3 = R4 = CH3, η = 2 6,0g 3-(2-Chlor-ethyl)-2,7,8,9-tetramethyl-pyrido[3', 2':4,5]thieno[3,2-d]pyrimidin-4(3H)-on (II; R1 = R2 = R3 = R4 = CH3, Schmp.: 218-2210C [Chloroform/Ethanol]; Ausbeute: 60%) werden in einer Mischung aus je 40ml 1,2-Diarhinoethanmonohydrat und DMF analog Beispiel 1 umgesetzt und aufgearbeitet. Schmp.: 286-2870C (DMF/Wasser); Ausbeute: 68%.5,7,8,9-tetramethyl-2,3-dihydro-pyrido [3 ', 2': 4,5] thieno [2,3-e] imidazole [1,2-c] pyrimidine I; R 1 = R 2 = R 3 = R 4 = CH 3 , η = 2 6.0 g 3- (2-chloroethyl) -2,7,8,9-tetramethylpyrido [3 ', 2': 4 , 5] thieno [3,2-d] pyrimidin-4 (3H) -one (II; R 1 = R 2 = R 3 = R 4 = CH 3, m.p .: 218-221 0 C [chloroform / ethanol] Yield: 60%) are reacted and worked up in a mixture of 40 ml of 1,2-diarhinoethane monohydrate and DMF analogously to Example 1. M.p .: 286-287 0 C (DMF / water); Yield: 68%.
6,8,9,10-Tetramethyl-3,4-dihydro-2H-pyrido[3', 2':4,5]thieno[2,3-e]pyrimido[1,2-c]pyrimidin I; R1 = R2 = R3 = R4 = CH3, η = 6,0g der im Beispiel 6 genannten Chlor-ethylverbindung der allgemeinen Formel Il werden in einer Mischung aus je 40 ml 1,3-Diamino-propan und DMF analog Beispiel 1 umgesetzt und aufgearbeitet. Schmp.: 286-2900C (DMF/Wasser); Ausbeute: 46%.6,8,9,10-tetramethyl-3,4-dihydro-2H-pyrido [3 ', 2': 4,5] thieno [2,3-e] pyrimido [1,2-c] pyrimidine I; R 1 = R 2 = R 3 = R 4 = CH 3 , η = 6.0 g of the chloro-ethyl compound of the general formula II mentioned in Example 6 are analogous in a mixture of 40 ml each of 1,3-diamino-propane and DMF Example 1 implemented and worked up. M.p .: 286-290 0 C (DMF / water); Yield: 46%.
7-(4-Chlor-phenyl)-5-methyl-2,3,8,9,10,11-hexahydroimidazo[1", 2":3', 4']pyrimido[5', 6':5,4]thieno[2,3-b]chinolin = 'V-W-Chlor-phenyD-S-methyl-S^-tetramethylen^S-dihydro-pyridoß', 2':4,5]thieno[2,3-e]imidazol[1,2-c]pyrimidin" I; R1 = CH3, R2 = P-CI-C6H4, R3R4 = -(CH2J4-, η = 27- (4-chloro-phenyl) -5-methyl-2,3,8,9,10,11-hexahydroimidazo [1 ", 2": 3 ', 4'] pyrimido [5 ', 6': 5, 4] thieno [2,3-b] quinoline = 'VW-chloro-phenyD-S-methyl-S ^ -tetramethylene ^ S-dihydro-pyridoxy', 2 ': 4,5] thieno [2,3-e] imidazole [1,2-c] pyrimidine "I; R 1 = CH 3 , R 2 = P-CI-C 6 H 4 , R 3 R 4 = - (CH 2 J 4 -, η = 2
0,9g3-(2-Chlor-ethyl)-11-(4-chlor-phenyl)-2-methyl-7,8,9,10-tetrahydro-pyrimido[4', 5':4,5]thieno[2,3-b]chinolin-4(3H)-on = "3-(2-Chlor-ethyl)-9-(4-chlor-phenyl)-2-methyl-7,8-tetramethylen-pyrido[3',2':4,5]thieno[3,2-d]pyrimidin-4(3H)-on" (II; R1 = CH3, R2 = P-CI-C6H4, R3R4 = -[CH2I4-; Schmp.: 247-255°C [Chloroform/Methanol]; Ausbeute: 88%), 8ml 1,2-Diaminoethanmonohydrat und 8ml DMF werden 30 min unter Rückfluß erhitzt. Nach dem Erkalten wird der gebildete Niederschlag abgesaugt, mit wäßrigem Methanol gewaschen und getrocknet0,9g3- (2-chloro-ethyl) -11- (4-chloro-phenyl) -2-methyl-7,8,9,10-tetrahydropyrimido [4 ', 5': 4,5] thieno [ 2,3-b] quinoline-4 (3H) -one = "3- (2-chloro-ethyl) -9- (4-chloro-phenyl) -2-methyl-7,8-tetramethylene-pyrido [3 ' , 2 ': 4,5] thieno [3,2-d] pyrimidin-4 (3H) -one "(II; R 1 = CH 3 , R 2 = P-CI-C 6 H 4 , R 3 R 4 = - [CH 2 I 4 -; mp: 247-255 ° C [chloroform / methanol]; yield: 88%), 8 ml of 1,2-diaminoethane monohydrate and 8 ml of DMF are refluxed for 30 minutes. After cooling, the precipitate formed is filtered off with suction, washed with aqueous methanol and dried
Schmp.: 285-2870C (Methanol/Wasser); Ausbeute: 61 %.M.p .: 285-287 0 C (methanol / water); Yield: 61%.
Weiterhin wurden aus nachfolgend aufgeführten Chlorethylverbindungen der allgemeinen Formel Il analog vorstehend genannter Beispiele folgende Verbindungen der allgemeinen Formel I synthetisiert:Furthermore, the following compounds of the general formula I were synthesized from the chloroethyl compounds of the general formula II listed below in analogy to the abovementioned examples:
5-Methyl-9-phenyl-2,3-dihydro-pyrido[3',2':4,5]thieno[2,3-e]imidazol[1,2-c]pyrimidinl;R1 = CH3, R2 = R3 = H, R4= C6H5, η = 2; Schmp.: 285-2900C (Ethanol); Ausbeute: 43%.5-methyl-9-phenyl-2,3-dihydro-pyrido [3 ', 2': 4,5] thieno [2,3-e] imidazo [1,2-c] pyrimidinl; R 1 = CH 3 , R 2 = R 3 = H, R 4 = C 6 H 5 , η = 2; M.p .: 285-290 0 C (ethanol); Yield: 43%.
5,7,9-Trimethyl-2,3-dihydro-pyrido[3', 2':4,5]thieno[2,3-e]imidazo[1,2-c]pyrimidin I; R1 = R2 = R4 = CH3, R3 = H, η = 2; Schmp.: 241-247°C (Ethanol/Wasser); Ausbeute: 80%.5,7,9-trimethyl-2,3-dihydro-pyrido [3 ', 2': 4,5] thieno [2,3-e] imidazo [1,2-c] pyrimidine I; R 1 = R 2 = R 4 = CH 3 , R 3 = H, η = 2; Mp: 241-247 ° C (ethanol / water); Yield: 80%.
9-(4-Brom-phenyl)-5,7-dimethyl-2,3-dihydro-pyrido[3', 2':4,5]thieno[2,3-e]imidazol[1,2-c]pyrimidin I; R1 = R2 = CH3, R3 = H, R4 = P-Br-C6H4, η = 2; Schmp.: 306-3080C (Ethanol/Dioxan); Ausbeute: 73%.9- (4-Bromo-phenyl) -5,7-dimethyl-2,3-dihydro-pyrido [3 ', 2': 4,5] thieno [2,3-e] imidazole [1,2-c] pyrimidine I; R 1 = R 2 = CH 3 , R 3 = H, R 4 = P-Br-C 6 H 4 , η = 2; M.p .: 306-308 0 C (ethanol / dioxane); Yield: 73%.
7-(4-Brom-phenyl)-5,9-dimethyl-2,3-dihydro-pyrido[3', 2':4,5/thieno[2,3-e]imidazo![1,2-c]pyrimidin I; R1 = R4 = CH3, R3 = H, R2 = P-Br-C6H4, η = 2; Schmp.: 279-2800C (Chloroform/Methanol); Ausbeute: 73%.7- (4-Bromo-phenyl) -5,9-dimethyl-2,3-dihydro-pyrido [3 ', 2': 4,5 / thieno [2,3-e] imidazo! [1,2-c ] pyrimidine I; R 1 = R 4 = CH 3 , R 3 = H, R 2 = P-Br-C 6 H 4 , η = 2; M.p .: 279-280 0 C (chloroform / methanol); Yield: 73%.
8-Benzyl-5,7,9-trimethyl-2,3-dihydro-pyrido[3', 2':4,5]thieno[2,3-e]imidazo[1,2-c]pyrimidin I; R1 = R2 = R4 = CH3, R3 = CH2C6H5, η = 2;8-Benzyl-5,7,9-trimethyl-2,3-dihydro-pyrido [3 ', 2': 4,5] thieno [2,3-e] imidazo [1,2-c] pyrimidine I; R 1 = R 2 = R 4 = CH 3 , R 3 = CH 2 C 6 H 5 , η = 2;
Die Herstellung der Verbindungen der allgemeinen Formel I erfolgte aus folgenden Verbindungen der allgemeinen Formel II:The compounds of general formula I were prepared from the following compounds of general formula II:
3-(2-Chlor-ethyl)-2-methyl-7-phenyl-pyrido[3', 2':4,5]thieno[3,2-d]pyrimidin-4(3H)-on II; R1 = CH3, R2 = R3 = H, R4 = C6H5; Schmp.: 235-24O0C (Chloroform/Methanol); Ausbeute: 95%.3- (2-Chloroethyl) -2-methyl-7-phenyl-pyrido [3 ', 2': 4,5] thieno [3,2-d] pyrimidin-4 (3H) -one II; R 1 = CH 3 , R 2 = R 3 = H, R 4 = C 6 H 5 ; Mp: 235-24O 0 C (chloroform / methanol); Yield: 95%.
3-(2-Chlor-ethyl)-2,7,9-trimethyl-pyrido[3',2':4,5]thieno[3,2-d]pyrimidin-4(3)-on II; R1 = R2 = R4 = CH3, R3 = H; Schmp.: 230-2330C (Chloroform/Methanol); Ausbeute: 95%.3- (2-Chloro-ethyl) -2,7,9-trimethyl-pyrido [3 ', 2': 4,5] thieno [3,2-d] pyrimidin-4 (3) -one II; R 1 = R 2 = R 4 = CH 3 , R 3 = H; M.p .: 230-233 0 C (chloroform / methanol); Yield: 95%.
7-(4-Brom-phenyl)-3-(2-chlor-ethyl)-2,9-dimethyl-pyrido[3', 2':4,5]thieno[3,2-d]pyrimidin-4(3H)-on II; R1 = R2 = Ch3, R3 = H, R4 = P-Br-C6H4;7- (4-Bromo-phenyl) -3- (2-chloro-ethyl) -2,9-dimethyl-pyrido [3 ', 2': 4,5] thieno [3,2-d] pyrimidine-4 ( 3H) -one II; R 1 = R 2 = Ch 3 , R 3 = H, R 4 = P-Br-C 6 H 4 ;
Schmp.: 291-293°C (Chloroform/Methanol); Ausbeute: 70%.Mp: 291-293 ° C (chloroform / methanol); Yield: 70%.
9-(4-Brom-phenyl)-3-(2-chlor-ethyl)-2,7-dimethyl-pyrido[3',2':4,5]thieno[3,2-d]pyrimidin-4(3H)-on II; R1 = R4 = CH3, R2 = p-Br-C6H4, R3 = H;9- (4-bromo-phenyl) -3- (2-chloro-ethyl) -2,7-dimethyl-pyrido [3 ', 2': 4,5] thieno [3,2-d] pyrimidin-4 ( 3H) -one II; R 1 = R 4 = CH 3 , R 2 = p-Br-C 6 H 4 , R 3 = H;
Schmp.: 230°C (Chloroform/Methanol); Ausbeute: 75%.Mp: 230 ° C (chloroform / methanol); Yield: 75%.
8-Benzyl-3-(2-chlor-ethyl)-2,7,9-trimethyl-pyrido[3', 2':4,5]thieno[3,2-d]pyrimidin-4(3H)-on II; R1 = R2 = R4 = CH3, R = CH2C6H5;8-Benzyl-3- (2-chloroethyl) -2,7,9-trimethyl-pyrido [3 ', 2': 4,5] thieno [3,2-d] pyrimidin-4 (3H) -one II; R 1 = R 2 = R 4 = CH 3 , R = CH 2 C 6 H 5;
Schmp.: 191-1930C (Chloroform/Ethanol); Ausbeute: 78%.M.p .: 191-193 0 C (chloroform / ethanol); Yield: 78%.
2,5g des entsprechend substituierten 3-(2-Hydroxy-ethyl)pyrido[3', 2':4,5]thieno[3,2-d]pyrimidin-4(3H)-ons und 30ml POCI3 werden 30min unter Rückfluß erhitzt, wobei klare Lösungen erhalten werden. Nach Abdestillieren des überschüssigen Phosphoroxidchlorids wird der Rückstand mit Eiswasser durchgearbeitet, das verbleibende feste Produkt abgesaugt, mit , Wasser und Methanol gewaschen und getrocknet.2.5 g of the correspondingly substituted 3- (2-hydroxyethyl) pyrido [3 ', 2': 4,5] thieno [3,2-d] pyrimidin-4 (3H) -one and 30 ml of POCl 3 are allowed to stand for 30 min Refluxed, whereby clear solutions are obtained. After distilling off the excess phosphorus oxychloride, the residue is worked up with ice-water, the remaining solid product is filtered off with suction, washed with water and methanol and dried.
Claims (1)
strukturanaloger -pyrimido[1,2-c]pyrimidine bzw. -1,3-diazepino[1,2-c]pyrimidine der allgemeinen Formel I, dadurch gekennzeichnet, daß 3-(2-Chlor-ethyl)pyrido[3', 2':4,5]thieno[3,2-d]pyrimidin-4(3H)-one der allgemeinen Formel Il1. A process for the preparation of pyrido [3 ', 2': 4,5] thieno [2,3-e] imidazo [1,2-c] pyrimidines and
structurally analogous pyrimido [1,2-c] pyrimidines or 1,3-diazepino [1,2-c] pyrimidines of the general formula I, characterized in that 3- (2-chloroethyl) pyrido [3 ', 2 ': 4,5] thieno [3,2-d] pyrimidin-4 (3H) -ones of the general formula II
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DD30047687A DD258234A1 (en) | 1987-03-05 | 1987-03-05 | PROCESS FOR THE PREPARATION OF PYRIDO / 3 ', 2': 4,5 / THIENO / 2,3-E / IMIDAZO- / 1,2-C / PYRIMIDINES AND STRUCTURE ANALOGER -PYRIMIDO / 1,2-C / PYRIMIDINE BZW. -1,3-diazepino / 1.2-C / PYRIMIDINES |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DD30047687A DD258234A1 (en) | 1987-03-05 | 1987-03-05 | PROCESS FOR THE PREPARATION OF PYRIDO / 3 ', 2': 4,5 / THIENO / 2,3-E / IMIDAZO- / 1,2-C / PYRIMIDINES AND STRUCTURE ANALOGER -PYRIMIDO / 1,2-C / PYRIMIDINE BZW. -1,3-diazepino / 1.2-C / PYRIMIDINES |
Publications (1)
Publication Number | Publication Date |
---|---|
DD258234A1 true DD258234A1 (en) | 1988-07-13 |
Family
ID=5587264
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD30047687A DD258234A1 (en) | 1987-03-05 | 1987-03-05 | PROCESS FOR THE PREPARATION OF PYRIDO / 3 ', 2': 4,5 / THIENO / 2,3-E / IMIDAZO- / 1,2-C / PYRIMIDINES AND STRUCTURE ANALOGER -PYRIMIDO / 1,2-C / PYRIMIDINE BZW. -1,3-diazepino / 1.2-C / PYRIMIDINES |
Country Status (1)
Country | Link |
---|---|
DD (1) | DD258234A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111051316A (en) * | 2017-09-07 | 2020-04-21 | 卫材R&D管理有限公司 | Pentacyclic compounds |
US11420980B2 (en) | 2019-03-05 | 2022-08-23 | Eisai R&D Management Co., Ltd. | Salt of pentacyclic compound and crystal thereof |
-
1987
- 1987-03-05 DD DD30047687A patent/DD258234A1/en not_active IP Right Cessation
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111051316A (en) * | 2017-09-07 | 2020-04-21 | 卫材R&D管理有限公司 | Pentacyclic compounds |
CN111051316B (en) * | 2017-09-07 | 2022-05-31 | 卫材R&D管理有限公司 | Pentacyclic compounds |
US11420980B2 (en) | 2019-03-05 | 2022-08-23 | Eisai R&D Management Co., Ltd. | Salt of pentacyclic compound and crystal thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2614406A1 (en) | TETRACYCLIC COMPOUNDS, METHODS OF MANUFACTURING THEREOF, AND MEDICINAL PRODUCTS, CONTAINING THESE COMPOUNDS | |
DE1197466B (en) | Process for the preparation of new 5, 6, 7, 8-tetrahydropyrido- [4, 3-d] pyrimidines | |
DD283394A5 (en) | METHOD FOR THE PRODUCTION OF INDILOCARBAZOL DERIVATIVES | |
DE4119767A1 (en) | Prepn. of (pyrimid-2-yl-thio- or seleno-) acetic acid derivs. - by reacting the corresp. chloro:alkanoyl-amino cpd. with a rhodanide and water or an alcohol | |
DD231355A5 (en) | PROCESS FOR THE PREPARATION OF NEW 2-PHENYL-UNIDAZOLENE | |
DE2720085C2 (en) | ||
EP0130461A2 (en) | Imidazoles, their preparation, and medicaments containing these compounds | |
DE2444322A1 (en) | TRIAZOLOPYRIDAZINE AND PROCESS FOR THE PREPARATION | |
DD258234A1 (en) | PROCESS FOR THE PREPARATION OF PYRIDO / 3 ', 2': 4,5 / THIENO / 2,3-E / IMIDAZO- / 1,2-C / PYRIMIDINES AND STRUCTURE ANALOGER -PYRIMIDO / 1,2-C / PYRIMIDINE BZW. -1,3-diazepino / 1.2-C / PYRIMIDINES | |
EP0130141A2 (en) | Beta-carbolines, process for their preparation and their use as medicaments | |
EP0184738A2 (en) | Imidazole derivatives, medicaments containing these compounds, and process for their preparation | |
DE1595889C3 (en) | ||
DE2301268A1 (en) | NEW PYRAZOLOPYRIDINS | |
DE2411273A1 (en) | Thieno (2,3-d) pyrimidinone derivs - for use as anti-inflammatories and inters, for antimicrobials | |
DD258233A1 (en) | PROCESS FOR THE PREPARATION OF IMIDAZO / 1,2-C / THIENO / 3,2-E / PYRIMIDINES BZW. OF STRUCTURE ANALOGS PYRIMIDO / 1,2-C / THIENO / 3,2-E / PYRIMIDINES | |
DE2244573A1 (en) | TRIAZOLO-BENZODIAZEPINE AND THE METHOD OF MANUFACTURING IT | |
DE2548737A1 (en) | 6-PHENYL-SPIRO- SQUARE CLAMP ON CYCLOPROPANE 1,4 'SQUARE CLAMP ON 4H SQUARE BRACKET FOR -S-TRIAZOLO SQUARE CLAMP ON 4.3-ANGLE BRACKET - SQUARE BRACKET ON 1.4 SQUARE BRACKET FOR BENZODIAZEPINE SQUARE CLIP TO AND METHOD OF MANUFACTURING THEREOF | |
LU82435A1 (en) | METHOD FOR THE PRODUCTION OF 3-SUBSTITUTED TETRAHYDROPYRROLO (1,2-A) PYRIMIDINES, AND THE COMPONENTS CONTAINING THE COMPOUNDS, AND NEW 3-SUBSTITUTED-TETRAHYDROPYRROY (1,2-A) | |
DD258232A1 (en) | METHOD OF PREPARING PREFERRED 8,9-DIMETHOXY SUBSTITUTED 2,3-DIHYDRO-IMIDAZO / 1,2-C / AND 9,10-DIMETHOXY SUBSTITUTED 3,4-DIHYDRO-2H-PYRIMIDO / 1,2-C / CHINAZOLINES | |
DD150605A5 (en) | PROCESS FOR PREPARING DIHALOGEN-SUBSTITUTED CONDENSED PYRIMIDIN-4-ON DERIVATIVES | |
DD258014A1 (en) | PROCESS FOR PREPARING 4-OXO-3,4-DIHYDRO-PYRIDO / 3 ', 2': 4,5 / -THIENO / 3,2-D / PYRIMIDIN-2-CARBONSAEUREAL CYLINDERS | |
DD258015A1 (en) | PROCESS FOR THE MANUFACTURE, IF APPLICABLE, IN 7,8-BZW. 8,9-POSITION CYCLOALIPHATICALLY-CRACKED 4-ALKOXY-PYRIDO- / 3 ', 2': 4,5 / THIENO / 3,2-D / PYRIMIDIN-2-CARBONSAEURES | |
AT394562B (en) | Process for the preparation of novel thienotriazolodiazepines | |
AT204557B (en) | Process for the preparation of new, alkylated 4- and / or 6-oxo-hydro-pyrazolo- [3,4-d] pyrimidines | |
DD257830A1 (en) | PROCESS FOR PREPARATION OF 3- (FUNCTIONALIZED) ALKYL-PYRIDO- / 3 ', 2': 4,5 / THIENO / 3,2-D / PYRIMIDIN-4 (3H) -ONEE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EPAE | Change in the person, name or address of the patentee | ||
UW | Conversion of economic patent into exclusive patent | ||
ENJ | Ceased due to non-payment of renewal fee |